# Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Chronic Low Back Pain

> **NCT04529096** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 149 (actual)

## Conditions studied

- Chronic Low-back Pain

## Interventions

- **DRUG:** LY3016859
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04529096
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-25
- **Primary completion:** 2021-06-04
- **Final completion:** 2021-10-04
- **Target enrollment:** 149 (ACTUAL)
- **Last updated:** 2023-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04529096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04529096, "Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Chronic Low Back Pain". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04529096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*